Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 7/20 | 0.59 |
| ▸ | FAAH | O00519 | 3/20 | 0.59 |
| ▸ | RXRA | P19793 | 1/20 | 0.58 |
| ▸ | RXRB | P28702 | 1/20 | 0.58 |
| ▸ | RXRG | P48443 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.55 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.55 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.55 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.55 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.55 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.55 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.55 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.55 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.55 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28737900 | 0.98 | MGLL (0.58) | MGLLFAAHRXRARXRBRXRG | |
| Hydrazine SCHEMBL27822007 | 0.97 | MGLL (0.56) | MGLLFAAHRXRARXRBRXRG | |
| SCHEMBL1823484 | 0.90 | PPARD (0.62) | MGLLFAAHMAPK1DDAH1PPARD | |
| Succinimide SCHEMBL132748 | 0.89 | MGLL (0.49) | MGLLFAAHRXRARXRBRXRG | |
| SCHEMBL8510655 | 0.89 | MGLL (0.49) | MGLLFAAHRXRARXRBRXRG | |
| SCHEMBL741572 | 0.87 | MGLL (0.59) | MGLLFAAHRXRARXRBRXRG | |
| Water SCHEMBL17644778 | 0.85 | MGLL (0.58) | MGLLFAAHRXRARXRBRXRG | |
| SCHEMBL12683541 | 0.85 | MGLL (0.62) | MGLLFAAHRXRARXRBRXRG | |
| SCHEMBL12657331 | 0.85 | MGLL (0.58) | MGLLFAAHRXRARXRBRXRG | |
| SCHEMBL8090506 | 0.84 | MGLL (0.56) | MGLLFAAHRXRARXRBRXRG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 745 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3965887-B1 | ANTIMICROBIAL CHITOSAN | UNIV GENEVE (CH) | 2024-02-28 | — | — | EP | claimed |
| CN-114874287-A | Synthetic method of antibody coupled drug-linker LND1042 | 联宁（苏州）生物制药有限公司 | 2022-08-09 | — | — | CN | claimed |
| EP-2804631-B1 | SURROBODY CONJUGATES | I2 PHARMACEUTICALS INC (US) | 2021-03-17 | — | — | EP | claimed |
| EP-2957632-B1 | ANTI-CDH3 HUMANIZED ANTIBODY, DRUG CONJUGATE THEREOF, AND UTILIZATION OF SAME | PERSEUS PROTEOMICS INC (JP) | 2020-09-30 | — | — | EP | claimed |
| CN-105770903-B | A kind of preparation method of temperature control drug-releasing polymer micro-sphere material | 南京理工大学 | 2019-01-18 | — | — | CN | claimed |
| EP-2675480-B1 | METHODS OF PREPARATION OF CONJUGATES | IMMUNOGEN INC (US) | 2018-12-26 | — | — | EP | claimed |
| CN-108939059-A | Albumen-cell conjugate, preparation method and use | 加思葆（北京）医药科技有限公司 | 2018-12-07 | — | — | CN | claimed |
| CN-108904797-A | Albumen-cell conjugate, preparation method and use | 加思葆（北京）医药科技有限公司 | 2018-11-30 | — | — | CN | claimed |
| EP-2854846-B1 | IMMUNOGENIC COMPOUNDS COMPRISING HIV GP41 PEPTIDE COUPLED TO CRM197 CARRIER PROTEIN | MINKA THERAPEUTICS (FR) | 2018-09-12 | — | — | EP | claimed |
| CN-104507496-B | Immunogenic compounds comprising HIV GP41 peptide coupled to CRM197 carrier protein | 伊纳维尔瓦克斯公司 | 2018-08-03 | — | — | CN | claimed |
| EP-0633029-B1 | Further improvements relating to drug delivery systems | CANCER RES CAMPAIGN TECH (GB) | 1997-11-26 | — | — | EP | claimed |
| EP-0396116-B1 | Covalent attachment of specific binding members to a solid phase | ABBOTT LAB (US) | 1997-02-05 | — | — | EP | claimed |
| EP-0751959-A1 | MODIFIED POLYPEPTIDES WITH INCREASED BIOLOGICAL ACTIVITY | NEW ENGLAND DEACONESS HOSPITAL (US) | 1997-01-08 | — | — | EP | claimed |
| US-5580853-A | ERYTHROPOIETIN WITH ATTACHED HETEROBIFUNCTIONAL CROSSLINKING REAGENT CONTAINING CLEAVABLE DISULFIDE BOND GROUP | NEW ENGLAND DEACONESS HOSPITAL (US) | 1996-12-03 | — | — | US | claimed |
| EP-0478715-B1 | TARGETED LIPOSOMES AND METHODS FOR LIPOSOME-PROTEIN COUPLING | LIPOSOME CO INC (US) | 1996-04-03 | — | — | EP | claimed |
| WO-1995025746-A1 | MODIFIED POLYPEPTIDES WITH INCREASED BIOLOGICAL ACTIVITY | NEW ENGLAND DEACONESS HOSPITAL (US) | 1995-09-28 | — | — | WO | claimed |
| EP-0649857-A1 | Peptide having inflammation affinity and radioactive diagnostic containing the same | NIHON MEDI-PHYSICS Co., Ltd. (JP) | 1995-04-26 | — | — | EP | claimed |
| EP-0366770-B1 | LIPOSOMES COUPLED TO HORMONES | VESTAR INC (US) | 1994-02-09 | — | — | EP | claimed |
| EP-0146050-B1 | SITE SELECTIVE PLASMINOGEN ACTIVATOR AND METHOD OF MAKING AND USING SAME | Callewaert, Denis M. (US) | 1990-07-04 | — | — | EP | claimed |
| WO-1983002946-A1 | ANTITUMORAL AGENTS, SUCH AS DAUNORUBICIN, HAVING AN IMPROVED ACTIVITY, OBTENTION THEREOF AND METHOD FOR ENHANCING THE ACTIVITY OF ANTITUMORAL AGENTS | RELYVELD, EDGAR, HANS | 1983-09-01 | — | — | WO | claimed |